Evidence Level
Strong
2 Clinical Trials
7 Documented Benefits
4/5 Evidence Score

Olive leaf extract is derived from Olea europaea leaves and contains oleuropein — the bitter polyphenol responsible for many of the cardiovascular benefits associated with the Mediterranean diet. Oleuropein concentrations are 30-40x higher in leaves than in olive oil itself. A 2025 meta-analysis of randomized trials found 1,000 mg/day reduced systolic blood pressure by roughly 11 mmHg and diastolic by 5 mmHg in pre-hypertensive and hypertensive adults — meaningful effect sizes comparable to mild antihypertensive medication. Effects on cholesterol and other lipid markers are less consistent (a well-designed 8-week RCT in overweight adults at 500 mg/day showed no significant lipid effects). EFSA recognizes olive polyphenols (5 mg hydroxytyrosol/day) for protection of blood lipids from oxidative stress — though hydroxytyrosol is more concentrated in olive fruit extracts than leaf extracts. The honest framing: meaningful blood pressure evidence at higher doses (1,000 mg/day); evidence for cholesterol, blood sugar, and antiviral applications is more variable. Branded standardized extracts (Witholytin®, EFLA®943) have stronger trial-grade evidence than generic preparations.

Studied Dose Standard dose: 500-1,000 mg/day standardized olive leaf extract (containing 20-40% oleuropein). Blood pressure protocols: 500 mg twice daily (1,000 mg/day total). Effects on blood pressure appear over 6-8 weeks of consistent use. Take with meals to support absorption.
Active Compound Oleuropein (typical standardization 18-40% in commercial extracts) plus secondary polyphenols including hydroxytyrosol, tyrosol, oleocanthal, and oleacein. Quality varies dramatically between commercial preparations.

Benefits

Blood pressure reduction (strongest evidence)

A 2025 systematic review and meta-analysis of randomized trials found olive leaf extract at 1,000 mg/day reduced systolic blood pressure by roughly 11 mmHg and diastolic by 5 mmHg in pre-hypertensive and hypertensive adults. Effect sizes are clinically meaningful and comparable to mild antihypertensive medication.

Cardiovascular and endothelial support

Olive leaf polyphenols improve vascular endothelial function and arterial elasticity in trials of pre-hypertensive and hypertensive adults. Mechanisms include nitric oxide-mediated vasodilation, reduced oxidative stress, and modest anti-inflammatory effects on vascular tissue.

Blood sugar regulation (modest evidence)

Trials in adults with type 2 diabetes and metabolic syndrome show olive leaf extract may improve fasting glucose, HbA1c, and insulin sensitivity over 12+ weeks of supplementation. Effect sizes are smaller than berberine or metformin but useful as adjunct support.

Antiviral and antimicrobial activity

In vitro and preclinical evidence shows oleuropein has antiviral activity against several common viruses. Human clinical evidence for cold and flu prevention is more limited — small trials suggest possible benefit but require confirmation in larger studies.

Antioxidant and anti-inflammatory effects

Olive leaf polyphenols reduce oxidative stress markers and inflammatory cytokines in clinical trials. Effects are modest but consistent and may underlie the broader cardiovascular and metabolic benefits observed at higher doses.

Honest counter-evidence on cholesterol

A well-designed 2020 RCT in overweight adults at 500 mg/day for 8 weeks showed no significant effects on blood lipids, oxidized LDL, blood pressure, glucose, or insulin. Suggests lipid effects may be smaller or require higher doses than blood pressure effects. The cholesterol-lowering positioning is less validated than the blood pressure positioning.

Standardization matters

Generic olive leaf extracts vary dramatically in oleuropein content (3-40%). Standardized branded extracts (Witholytin®, EFLA®943, Bonolive®) have stronger trial-grade evidence than unstandardized preparations. Cost per gram of standardized oleuropein is a more meaningful price comparison than raw mg of extract.

Mechanism of action

1

ACE inhibition and vasodilation

Oleuropein and hydroxytyrosol inhibit angiotensin-converting enzyme (ACE) — the same target as captopril and lisinopril. ACE inhibition reduces angiotensin II production, decreasing vasoconstriction and aldosterone release, leading to blood pressure reduction and improved renal function.

2

GLUT4 translocation and insulin sensitization

Oleuropein activates AMPK and promotes GLUT4 glucose transporter translocation to the cell membrane independently of insulin signaling, improving skeletal muscle glucose uptake and insulin sensitivity — a mechanism shared with metformin but through a different upstream pathway.

3

LDL oxidation prevention

Hydroxytyrosol integrates into LDL particle membranes and directly prevents oxidative modification of LDL cholesterol by reactive oxygen species — the initiating event in atherosclerotic plaque formation. This is the basis of the EFSA-approved cardiovascular health claim for olive polyphenols.

Clinical trials

1
Olive Leaf Extract vs Captopril for Hypertension — RCT
PubMed

Randomized, double-blind, parallel trial in 232 patients with stage 1 hypertension comparing olive leaf extract (500 mg twice daily standardized to oleuropein) vs captopril (12.5 mg twice daily) for 8 weeks. (Susalit et al. 2011, Phytomedicine)

232 stage 1 hypertensive patients.

Olive leaf extract produced equivalent BP reductions to captopril (-11.5/-4.8 mmHg vs -13.7/-6.4 mmHg). Comparable efficacy with fewer adverse events. Critical context: captopril is an ACE inhibitor — first-generation; modern hypertension management uses ARBs, calcium channel blockers, thiazides, etc. The 'as effective as ACE inhibitor' claim is reasonable for stage 1 hypertension but should be tempered — guideline-directed antihypertensive therapy remains foundational.

2
Olive Leaf Extract for Insulin Resistance — Crossover RCT
PubMed

Randomized, double-blind crossover trial of olive leaf extract (51.1 mg oleuropein + 9.7 mg hydroxytyrosol/day) vs placebo in 46 overweight men at risk of metabolic syndrome for 12 weeks each. (de Bock et al. 2013, PLoS One)

46 overweight men. 12-week crossover.

Olive leaf extract improved insulin sensitivity (~29% improvement in HOMA-IR) and pancreatic beta-cell responsiveness vs placebo. Modest effects.

Side effects and drug interactions

Common Potential side effects

Generally very well tolerated; excellent safety profile
Mild GI effects (nausea, loose stools) at high doses in sensitive individuals
Detox-like symptoms (headache, fatigue) during first few days of use — attributed to antimicrobial activity effects on gut microbiome

Important Drug interactions

Antihypertensive medications — additive blood pressure-lowering effects; monitor blood pressure carefully; potential to reduce medication dose requirement
Antidiabetic medications (metformin, insulin) — additive glucose-lowering; monitor blood sugar
Anticoagulants (warfarin) — hydroxytyrosol inhibits platelet aggregation; monitor INR
Chemotherapy — olive polyphenols have antioxidant activity; theoretical concern; discuss with oncologist

Frequently asked questions about Olive Leaf Extract

How much olive leaf extract should I take?

Studies commonly use 500 to 1,000 mg per day of olive leaf extract, often standardized to oleuropein (a key polyphenol). Some blood-pressure research uses standardized extracts in this range.

What is olive leaf extract used for?

Olive leaf extract is studied for supporting healthy blood pressure, antioxidant activity, immune support, and healthy blood sugar. Its main active compound, oleuropein, drives much of its activity.

When should I take olive leaf extract?

It can be taken once or twice daily, with food. For blood-pressure support, consistent daily use over several weeks is the studied approach. Splitting the dose is common.

Does olive leaf extract have side effects?

It is generally well tolerated; occasional effects include mild stomach upset or headache. Because it may lower blood pressure and blood sugar, use caution if you take medication for either, and check with your doctor.

What is Olive Leaf Extract?

Olive leaf extract is derived from Olea europaea leaves and contains oleuropein — the bitter polyphenol responsible for many of the cardiovascular benefits associated with the Mediterranean diet. Oleuropein concentrations are 30-40x higher in leaves than in olive oil itself.

What is the recommended dosage of Olive Leaf Extract?

The clinically studied dose is Standard dose: 500-1,000 mg/day standardized olive leaf extract (containing 20-40% oleuropein). Blood pressure protocols: 500 mg twice daily (1,000 mg/day total). Effects on blood pressure appear over 6-8 weeks of consistent use. Always follow the product label and check with a healthcare provider for personal advice.

Is Olive Leaf Extract safe, and does it have side effects?

For most healthy adults, Olive Leaf Extract is well tolerated at studied doses. Reported effects can include: Generally very well tolerated; excellent safety profile Mild GI effects (nausea, loose stools) at high doses in sensitive individuals It may also interact with some medications. Olive Leaf Extract is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Olive Leaf Extract interact with any medications?

Possible interactions include: Antihypertensive medications — additive blood pressure-lowering effects; monitor blood pressure carefully; potential to reduce medication dose requirement Antidiabetic medications (metformin, insulin) — additive glucose-lowering; monitor blood sugar If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Olive Leaf Extract?

NutraSmarts rates the evidence for Olive Leaf Extract as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Susalit E, Agus N, Effendi I, Tjandrawinata RR, Nofiarny D, Perrinjaquet-Moccetti T, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine. 2011;18(4):251-8. doi: 10.1016/j.phymed.2010.08.016.PubMedUsed to support: Double-blind active-controlled RCT in stage-1 hypertension: olive leaf extract (EFLA943, 500 mg twice daily) produced systolic/diastolic BP reductions comparable to captopril 12.5-25 mg twice daily over 8 weeks, and also lowered triglycerides. Key support for the blood-pressure-lowering claim; promising but single small trial.
  2. Lockyer S, Rowland I, Spencer JPE, Yaqoob P, Stonehouse W. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial. Eur J Nutr. 2017;56(4):1421-1432. doi: 10.1007/s00394-016-1188-y.PubMedUsed to support: Randomized double-blind crossover RCT in pre-hypertensive men: olive leaf extract (high in oleuropein/hydroxytyrosol) significantly lowered daytime and 24-h blood pressure and reduced total and LDL cholesterol versus control. Supports BP and lipid benefit; modest effect size, small sample.
  3. Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res. 2008;22(9):1239-42. doi: 10.1002/ptr.2455.PubMedUsed to support: Twin study (40 borderline-hypertensive monozygotic twins) showing a dose-dependent within-pair reduction in blood pressure with olive leaf extract (EFLA943), plus lower cholesterol. Adds genetically-controlled support for the BP effect, though open-label design and small size limit strength.
  4. de Bock M, Derraik JG, Brennan CM, Biggs JB, Morgan PE, Hodgkinson SC, et al. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One. 2013;8(3):e57622. doi: 10.1371/journal.pone.0057622.PubMedUsed to support: Randomized placebo-controlled crossover trial: 12 weeks of olive leaf polyphenols improved insulin sensitivity (about 15%) and pancreatic beta-cell responsiveness in overweight men. Supports a metabolic/antioxidant-related benefit; exploratory, small single trial without change in body weight or lipids.